Cite
HARVARD Citation
Pencharz, D. et al. (2022). Absence of clinical benefit of FDG PET-CT in staging T1 part-solid lung adenocarcinoma. Clinical radiology. 77 (3), pp. 195-202. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pencharz, D. et al. (2022). Absence of clinical benefit of FDG PET-CT in staging T1 part-solid lung adenocarcinoma. Clinical radiology. 77 (3), pp. 195-202. [Online].